36 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
. TABLE OF CONTENTS 6
PART I Item 1. Business Overview POINT Biopharma Global Inc. is a next-generation radioligand company. Our mission … is to accelerate the discovery, development and global access to targeted radioligand therapies. In pursuit of this mission, we have built a platform
424B3
pxalmo5ndyrx7m
13 May 22
Prospectus supplement
8:18am
424B3
kdaucroxrv76
31 Mar 22
Prospectus supplement
11:42am
POS AM
evx5yls vlgedx9er1a
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
EX-99.1
3p7 j4m559bir2
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
6tl9l
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
EX-99.1
ngifen1 tira7z
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
h1jh4o2p9rjdyc6cvi
12 Nov 21
Prospectus supplement
8:41am
424B3
pxqqwvb
28 Sep 21
Prospectus supplement
9:07am
8-K
EX-99.1
6jmf4hi 536li0e
28 Sep 21
Entry into a Material Definitive Agreement
8:53am